Elke Seewaldt-Becker

1.3k total citations · 1 hit paper
7 papers, 1.1k citations indexed

About

Elke Seewaldt-Becker is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Elke Seewaldt-Becker has authored 7 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Elke Seewaldt-Becker's work include Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (2 papers) and Diabetes Management and Research (2 papers). Elke Seewaldt-Becker is often cited by papers focused on Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (2 papers) and Diabetes Management and Research (2 papers). Elke Seewaldt-Becker collaborates with scholars based in Germany, United States and Egypt. Elke Seewaldt-Becker's co-authors include Hans J. Woerle, Thomas Meinicke, Hans‐Ulrich Häring, Ludwig Merker, Marc Weimer, Uli C. Broedl, Sabine Pinnetti, Stefan Hantel, Leo Seman and Tim Heise and has published in prestigious journals such as Diabetes Care, European Journal of Medicinal Chemistry and Journal of Hypertension.

In The Last Decade

Elke Seewaldt-Becker

7 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial

2014 315 citations Hans‐Ulrich Häring, Ludwig Merker et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elke Seewaldt-Becker Germany	7	972	588	510	160	84	7	1.1k
Ludwig Merker Germany	10	1.3k 1.4×	719 1.2×	525 1.0×	193 1.2×	79 0.9×	30	1.4k
Katja Rohwedder Germany	12	1.2k 1.3×	577 1.0×	698 1.4×	275 1.7×	77 0.9×	35	1.3k
S. Durán‐García Spain	11	978 1.0×	441 0.8×	497 1.0×	189 1.2×	45 0.5×	20	1.1k
Paul Strumph United States	14	1.2k 1.2×	811 1.4×	294 0.6×	82 0.5×	37 0.4×	25	1.3k
Zin Zin Htike United Kingdom	10	804 0.8×	283 0.5×	365 0.7×	180 1.1×	44 0.5×	14	924
Yoshishige Samukawa Japan	13	759 0.8×	336 0.6×	399 0.8×	138 0.9×	207 2.5×	25	918
Michaël J.B. van Baar Netherlands	7	656 0.7×	311 0.5×	233 0.5×	108 0.7×	166 2.0×	12	773
Xiaoni Liu China	11	600 0.6×	355 0.6×	319 0.6×	107 0.7×	93 1.1×	21	803
Nobuko Maruyama Japan	12	566 0.6×	321 0.5×	254 0.5×	77 0.5×	36 0.4×	14	618
Aurora Merovci United States	12	995 1.0×	642 1.1×	625 1.2×	118 0.7×	42 0.5×	17	1.2k

Countries citing papers authored by Elke Seewaldt-Becker

Since Specialization

Citations

This map shows the geographic impact of Elke Seewaldt-Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Seewaldt-Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Seewaldt-Becker more than expected).

Fields of papers citing papers by Elke Seewaldt-Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Seewaldt-Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Seewaldt-Becker. The network helps show where Elke Seewaldt-Becker may publish in the future.

Co-authorship network of co-authors of Elke Seewaldt-Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Seewaldt-Becker. A scholar is included among the top collaborators of Elke Seewaldt-Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Seewaldt-Becker. Elke Seewaldt-Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Häring, Hans‐Ulrich, Ludwig Merker, Elke Seewaldt-Becker, et al.. (2014). Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care. 37(6). 1650–1659. 315 indexed citations breakdown →

2.

Ferrannini, Ele, Leo Seman, Elke Seewaldt-Becker, et al.. (2013). A P hase IIb , randomized, placebo‐controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 15(8). 721–728. 160 indexed citations

3.

Häring, Hans‐Ulrich, Ludwig Merker, Elke Seewaldt-Becker, et al.. (2013). Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes. Diabetes Care. 36(11). 3396–3404. 305 indexed citations

4.

Heise, Tim, Elke Seewaldt-Becker, Sreeraj Macha, et al.. (2013). Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 15(7). 613–621. 231 indexed citations

5.

Manolis, Athanasios, et al.. (2004). Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study. Journal of Hypertension. 22(5). 1033–1037. 21 indexed citations

6.

Guth, Brian D., Elke Seewaldt-Becker, Frank Himmelsbach, H Weisenberger, & Thomas Müller. (1997). Antagonism of the GPIIb/IIIa Receptor with the Nonpeptidic Molecule BIBU52: Inhibition of Platelet Aggregation In Vitro and Antithrombotic Efficacy In Vivo. Journal of Cardiovascular Pharmacology. 30(2). 261–272. 12 indexed citations

7.

Himmelsbach, Frank, Volkhard Austel, Brian D. Guth, et al.. (1995). DESIGN OF HIGHLY POTENT NONPEPTIDIC FIBRINOGEN RECEPTOR ANTAGONISTS. European Journal of Medicinal Chemistry. 30. 243s–254s. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact